Joshua Csonka
Family · Conway, ARNPI 1942922547
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 69 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $425, 4.4 times the $96 reported in 2022.
Across 69 payments — averaging $18.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$217
- AstraZeneca$184
- Novo Nordisk$178
- Bayer$84
- Lilly USA, LLC$78
- AbbVie$73
- plus $458 from 16 others
What the payments were for
- Food & beverage$1,271100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 10 | $217 |
| AstraZeneca | 10 | $184 |
| Novo Nordisk | 10 | $178 |
| Bayer | 4 | $84 |
| Lilly USA, LLC | 5 | $78 |
| AbbVie | 4 | $73 |
| Supernus Pharmaceuticals, Inc. | 3 | $63 |
| Amgen | 3 | $60 |
| GSK | 3 | $50 |
| Currax Pharmaceuticals LLC | 3 | $49 |
| Exact Sciences | 2 | $28 |
| Vertex | 1 | $28 |
| Johnson & Johnson | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Merck | 1 | $21 |
| Seqirus USA Inc | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
| Boehringer Ingelheim | 1 | $18 |
| Corium, LLC | 2 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
| Nevro Corp. | 1 | $13 |
How this compares
$1,271 in reported general payments places this provider in the 70th percentile of 2,103 family providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $12,962 |
| JardianceEmpagliflozin | 19 | $11,548 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $7,389 |
| FarxigaDapagliflozin Propanediol | 12 | $6,591 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 41 | $429 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 17 | $338 |
| Doxycycline Hyclate | 34 | $304 |
| Azithromycin | 63 | $254 |
| Methylprednisolone | 30 | $234 |
| Levothyroxine Sodium | 28 | $217 |
| Amlodipine Besylate | 27 | $198 |
| Cefdinir | 16 | $188 |
| Mupirocin | 35 | $185 |
| Gabapentin | 21 | $174 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $174 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBreztri Aerosphere, Farxiga | $184 | $13,98024 claims |
| GSKTrelegy Ellipta | $50 | $12,96220 claims |
| Boehringer IngelheimJardiance | $18 | $11,54819 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,103 family providers in Arkansas.
Other family in Conway
- Meghan MallettConway$25K
- Sheila ForresterConway$17K
- Elana RussellConway$17K
- Donald KulbethConway$12K
- Kayla JohnsonConway$9K
- Crystal BrownConway$9K
- Leah CarringtonRogers$1.6M
- Nina CopelandFort Smith$207K
- Stefanie BrackinJonesboro$51K
- Amanda DavisFort Smith$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.